Skip to content

Clinical study on acupoint application of fine-tuning external application formula to intervene in delayed CINV

Clinical study on acupoint application of fine-tuning external application formula to intervene in delayed CINV

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055448
Enrollment
Unknown
Registered
2022-01-10
Start date
2022-01-05
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy induced nausea and vomiting (CINV)

Interventions

Sponsors

Wuxi Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. Patients with a clear diagnosis of malignant tumor; 3. Those receiving platinum-based chemotherapy; 4. Have received >= 1 course of chemotherapy before enrollment, and plan to receive >= 2 courses of chemotherapy; 5. Those with normal language expression ability and the ability to judge their own situation; 6. Good compliance and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with mechanical obstruction confirmed by gastroscope or gastrointestinal angiography; 2. Have other diseases that may cause nausea and vomiting, such as brain metastasis, hypothyroidism, etc.; 3. Those who cannot determine the curative effect due to incomplete data; 4. Patients with intellectual or mental disorders.

Design outcomes

Primary

MeasureTime frame
nausea;vomiting;

Countries

China

Contacts

Public ContactZhu Xiaodan

Wuxi Affiliated Hospital of Nanjing University of Traditional Chinese Medicine

pwtyz@126.com+86 13665187186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026